Want to see JP:7776 full AI Analyst Report?
CellSeed Inc. (7776) AI Stock Analysis
CellSeed Inc.
(TSE/TYO:7776)
The overall score is driven down by severe fundamental distress and sustained bearish price action. Accelerating cash burn and deep unprofitability are the primary risks, overwhelming the minor benefit of a low debt burden. Technical indicators firmly reflect negative sentiment.
CellSeed Inc. (7776) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 7.41B
- Dividend Yield
- ―
- Average Volume (3M)
- 167.52K
- Price to Earnings (P/E)
- -6.5
- Beta (1Y)
- 1.03
- Revenue Growth
- -56.16%
- EPS Growth
- 3.12%
- Country
- Japan
- Employees
- 36
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
CellSeed Inc. Business Overview & Revenue Model
Company Description
CellSeed Inc. focuses on pioneering regenerative therapies that utilize cell sheet technology. The company is deeply involved in the research, development, and market introduction of advanced cell-sheet medicine products. Its innovations encompass ep...
CellSeed Inc. Financial Statement Overview
Summary
Financial health is severely distressed. Despite low leverage, a sharp 56% revenue decline, widening net losses, and an unsustainable cash burn rate pose significant liquidity risks.
Income Statement
12Very NegativeBalance Sheet
45NeutralCash Flow
10Very Negative| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 83.68M | 193.28M | 190.13M | 126.43M | 161.67M |
| Gross Profit | 42.75M | 110.11M | 107.16M | 61.02M | 84.04M |
| EBITDA | -1.05B | -855.49M | -836.52M | -750.00M | -905.67M |
| Net Income | -1.10B | -859.84M | -846.53M | -759.68M | -912.87M |
Balance Sheet | |||||
| Total Assets | 1.66B | 2.43B | 2.47B | 1.54B | 1.41B |
| Cash, Cash Equivalents and Short-Term Investments | 1.32B | 2.13B | 2.16B | 1.07B | 846.67M |
| Total Debt | 132.92M | 143.75M | 151.25M | 158.75M | 160.00M |
| Total Liabilities | 387.46M | 269.88M | 301.05M | 365.58M | 363.58M |
| Stockholders Equity | 1.27B | 2.16B | 2.16B | 1.18B | 1.04B |
Cash Flow | |||||
| Free Cash Flow | -1.02B | -884.47M | -801.07M | -733.60M | -908.15M |
| Operating Cash Flow | -988.98M | -866.10M | -779.43M | -718.01M | -817.15M |
| Investing Cash Flow | -26.72M | -18.37M | 56.31M | 61.73M | -110.44M |
| Financing Cash Flow | 200.30M | 855.48M | 1.81B | 881.81M | 396.88M |
CellSeed Inc. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7776, the sentiment is Negative. The current price of 188.00 is below the 20-day moving average (MA) of 201.75, below the 50-day MA of 216.44, and below the 200-day MA of 257.88, indicating a bearish trend. The MACD of -7.85 indicates Positive momentum. The RSI at 34.83 is Neutral, neither overbought nor oversold. The STOCH value of 58.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:7776.
CellSeed Inc. Peers Comparison
Overall Rating
JP:709666Neutral
JP:459348Neutral
JP:497842Neutral
JP:777442Neutral
JP:459940Underperform- JP:777639Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:7096 | 66Neutral | JPY 7.18B | 48.11 | ― | ― | 4.85% | -40.57% |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| JP:4593 | 48Neutral | JPY 37.00B | 55.04 | ― | ― | -47.32% | ― |
| JP:4978 | 42Neutral | JPY 13.03B | -26.58 | ― | ― | -18.71% | -246.54% |
| JP:7774 | 42Neutral | JPY 25.54B | -58.02 | ― | ― | 3.43% | -53.59% |
| JP:4599 | 40Underperform | JPY 8.71B | -4.68 | ― | ― | ― | 4.85% |
| JP:7776 | 39Underperform | JPY 7.43B | -6.49 | ― | ― | -56.16% | 3.12% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:7776 | CellSeed Inc. | 188.00 | -249.00 | -56.98% | |
| JP:4593 | Healios KK | 273.00 | -221.00 | -44.74% | |
| JP:4599 | StemRIM Inc. | 139.00 | -134.00 | -49.08% | |
| JP:4978 | ReproCELL Inc. | 122.00 | -51.00 | -29.48% | |
| JP:7096 | StemCell Institute | 701.00 | -109.00 | -13.46% | |
| JP:7774 | Japan Tissue Engineering Co., Ltd. | 629.00 | 153.00 | 32.14% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Sep 06, 2026